Search by Drug Name or NDC

NDC 55513-0192-01 Neulasta Details

Neulasta

Neulasta is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amgen Inc. The primary component is .

MedlinePlus Drug Summary

Pegfilgrastim injection products are used to reduce the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Pegfilgrastim injection (Neulasta) is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to bone marrow. Pegfilgrastim is in a class of medications called colony stimulating factors. It works by helping the body make more neutrophils.

Related Packages: 55513-0192-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pegfilgrastim Injection

Product Information

NDC	55513-0192
Product ID	55513-192_50374606-0a76-45df-8b19-8323cc511e87
Associated GPIs	8240157000F820
GCN Sequence Number	073319
GCN Sequence Number Description	pegfilgrastim SYR W/ INJ 6 MG/0.6ML SUBCUT
HIC3	N1C
HIC3 Description	LEUKOCYTE (WBC) STIMULANTS
GCN	37706
HICL Sequence Number	023255
HICL Sequence Number Description	PEGFILGRASTIM
Brand/Generic	Brand
Proprietary Name	Neulasta
Proprietary Name Suffix	n/a
Non-Proprietary Name	pegfilgrastim
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	KIT
Route	n/a
Active Ingredient Strength	n/a
Active Ingredient Units	n/a
Substance Name	n/a
Labeler Name	Amgen Inc
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	BLA
Application Number	BLA125031
Listing Certified Through	2024-12-31

Package

NDC 55513-0192-01 (55513019201)

Pricing Information	N/A
NDC Package Code	55513-192-01
Billing NDC	55513019201
Package	1 KIT in 1 CARTON (55513-192-01) * .6 mL in 1 SYRINGE
Marketing Start Date	2015-02-20
NDC Exclude Flag	N